Harbor Health Care

Global healthcare companies

(WELP)
£5.61
Previous business day’s close price
£0.39 (‑6.46%)
max available period
£4.79
£8.75

08 Apr 19
08 Nov 24

Details

ETF description

This ETF invests in companies that are involved in the healthcare industry, focusing on sectors experiencing rapid growth and innovation. The fund targets businesses that are developing cutting‑edge technologies, products, and services in areas such as biotechnology, medical devices, pharmaceuticals, and healthcare services.

This ETF may appeal to investors who are interested in the healthcare sector and are looking for exposure to companies driving innovation in medical science and healthcare delivery. The fund offers an equal‑weight approach, ensuring balanced exposure to each company within its portfolio.

Issuer details

HanETF is an independent asset management firm known for being the first independent white‑label ETF platform in Europe. With over $4 billion in assets under management as of June 2024, HanETF offers a diverse range of ETFs. Established in 2017 by Hector McNeil and Nik Bienkowski, HanETF focuses on providing market exposures through collaboration with asset managers to bring investment ideas to market.

Index details

The Healthcare ETF is actively managed by the expert team at Westfield Capital Management.

Westfield Capital uses a bottom‑up process to identify companies that meet their strict fundamental criteria and then performs a qualitative review on each identified company to select approximately 30 to 50 companies for inclusion in the active Healthcare ETF’s portfolio. The Subadvisor’s research may include personal interviews and other contact with company management.

This ETF is in collections:

ETF Breakdown

Alnylam Pharmaceuticals Inc
1.5%
Adaptive Biotechnologies Corp
1.4%
Veracyte Inc
1.3%
Lantheus Holdings Inc
1.3%
JMDC Inc.
1.2%
Exact Sciences Corp.
1.2%
Procept BioRobotics Corp
1.2%
Asahi Intecc Co. Ltd.
1.2%
Genedx Holdings Corp
1.2%
Supernus Pharmaceuticals Inc
1.2%
QuidelOrtho Corporation
1.2%
Neogenomics Inc.
1.2%
Sosei Group Corp.
1.2%
Phreesia Inc
1.2%
Sysmex Corporation
1.2%
BeiGene Ltd
1.1%
Smith & Nephew plc
1.1%
Straumann Holding AG
1.1%
Biomerieux
1.1%
Harmony Biosciences Holdings Inc
1.1%
Illumina Inc
1.1%
Fisher & Paykel Healthcare Corporation Limited
1.1%
Terumo Corporation
1.1%
10x Genomics Inc
1.1%
Teleflex Incorporated
1.1%
Olympus Corp.
1.1%
Penumbra Inc
1.1%
Glaukos Corporation
1.1%
Sonova Holding AG
1.1%
SK bioscience Co. Ltd.
1.1%
Beam Therapeutics Inc
1.1%
Amicus Therapeutics Inc
1.1%
Alector Inc
1.1%
Myriad Genetics, Inc.
1.1%
Koninklijke Philips N.V.
1.1%
Regeneron Pharmaceuticals, Inc.
1.1%
Natera Inc
1.1%
Diasorin S.p.A.
1.1%
Neurocrine Biosciences, Inc.
1.0%
Merit Medical Systems, Inc.
1.0%
Intuitive Surgical Inc
1.0%
Alkermes plc
1.0%
Medtronic Plc
1.0%
Qiagen N.V.
1.0%
Resmed Inc.
1.0%
Hologic, Inc.
1.0%
Shop Apotheke Europe N.V.
1.0%
Bio‑Rad Laboratories Inc.
1.0%
Integer Holdings Corp
1.0%
Elekta AB (publ)
1.0%
Xenon Pharmaceuticals Inc
1.0%
Globus Medical Inc
1.0%
Steris Plc
1.0%
Veeva Systems Inc
1.0%
Biomarin Pharmaceutical Inc.
1.0%
Conmed Corp (Pre‑Merger)
1.0%
Ge Healthcare Technologies Inc
1.0%
Zimmer Biomet Holdings Inc
1.0%
PeptiDream Inc.
1.0%
Telix Pharmaceuticals Limited
1.0%
Pacific Biosciences of California Inc
1.0%
Schrodinger Inc
1.0%
Agilent Technologies Inc.
1.0%
Jazz Pharmaceuticals plc
1.0%
Acadia Pharmaceuticals Inc
1.0%
Lunit Inc
1.0%
Shandong Weigao Group Medical Polymer Co. Ltd.
0.9%
Boston Scientific Corp.
0.9%
Siemens Healthineers AG
0.9%
Prothena Corporation plc
0.9%
Regenxbio Inc
0.9%
Sectra Ab (Publ
0.9%
Intellia Therapeutics Inc
0.9%
Intra‑Cellular Therapies Inc
0.9%
Align Technology, Inc.
0.9%
Cochlear Ltd.
0.9%
Demant AS
0.9%
Inari Medical Inc
0.9%
PTC Therapeutics Inc
0.9%
Biogen Inc
0.8%
West Pharmaceutical Services, Inc.
0.8%
Insulet Corporation
0.8%
Recursion Pharmaceuticals Inc
0.8%
Ping An Healthcare And Technology Company Limited
0.8%
Sarepta Therapeutics Inc
0.8%
CRISPR Therapeutics AG
0.8%
Twist Bioscience Corp
0.8%
Alibaba Group Holding Ltd
0.8%
Arcturus Therapeutics Holdings Inc
0.7%
BioArctic AB
0.7%
Neuren Pharmaceuticals Ltd
0.7%
Edwards Lifesciences Corp
0.7%
Yidu Tech Inc.
0.7%
Teladoc Health Inc
0.7%
Sage Therapeutics Inc
0.7%
Hims & Hers Health Inc
0.7%
Zur Rose Group AG
0.7%
iRhythm Technologies Inc
0.6%
4D Molecular Therapeutics Inc
0.6%
Dexcom Inc
0.6%
Shanghai MicroPort MedBot (Group) Co.Ltd.
0.6%
Others
0.3%
£5.61
Previous business day’s close price

Capital at risk

Why InvestEngine

Unbeatable value

From commission‑free investing, to zero‑ISA fees, we’re proud of our low fees.
Here's how we're able to do it

Choice of 700+ ETFs

Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
View our ETF range

Actionable insights

Know exactly which companies, sectors and regions are in your portfolio.

Powerful automation

Grow your wealth the easy way with automated investing features

Easy diversification

Fractional investing lets you put as little as £1 in any ETF.

DIY or Managed

Build and manage your own portfolio or leave it to us.
ETFs have spreads and annual charges and come with risks like market volatility, liquidity, and concentration, and may not always accurately track their index. Past performance and forecasts are not reliable indicators of future results. The value of your investments, including any income, can rise or fall. You may get back less than you originally invested.
Whenever you invest, your capital is at risk
This could mean the value of your investments goes down as well as up.
Understand more about investment risk.
© InvestEngine Limited 2024. All rights reserved.